Tag: MHRA

GMP Investigation Steps for Texture Grittiness Complaints Following Packaging Changes In pharmaceutical manufacturing, changes in packaging can inadvertently lead to unexpected product quality issues, such as texture grittiness. Such complaints…

E&L Failure in Dental Gel Manufacturing: Investigating Quality Management Trends and Complaint Handling In the pharmaceutical manufacturing landscape, particularly in dental gel production, extractables and leachables (E&L) failures pose significant…

Root Cause Assessment of Content Uniformity Failures Following Supplier Changes In the pharmaceutical industry, ensuring content uniformity is critical for the regulatory compliance, safety, and efficacy of dosage forms. A…

Investigating Assay OOS: Managing Compliance and Complaint Handling in Pharmaceutical Inspections During the manufacturing process of dental dosage forms, unexpected Out of Specification (OOS) results can arise, particularly concerning assay…

Assessing Grittiness Complaints: Differentiating Between Manufacturing and Lab Root Causes in Dental Gel Production In pharmaceutical manufacturing, particularly within the dental gel segment, complaints regarding texture grittiness can pose serious…

Investigating Texture Grittiness Complaints During Method Transfer in Pharmaceutical Manufacturing In the highly regulated world of pharmaceutical manufacturing, texture complaints, such as grittiness, can pose significant challenges, particularly during method…

Addressing E&L Failures Following Supplier Adjustments in Pharmaceutical Manufacturing The pharmaceutical sector is no stranger to challenges, particularly when it comes to ensuring the compatibility of packaging materials with drug…

Addressing Viscosity Drift Issues During Bulk Hold: An Investigation Framework Viscosity drift during bulk hold poses significant challenges in pharmaceutical manufacturing, particularly for dosage forms such as dental preparations. Deviations…